Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Ophthalmic Ointment in Bacterial Conjunctivitis
NCT02432807Phase 3Completed
- Start
- May 2015
- Primary completion
- May 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin in bacterial conjunctivitis (BC). Started May 2015; status: completed.
02
Drugs
vancomycin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT02432807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432807.